1. Home
  2. BSP vs GMAB Comparison

BSP vs GMAB Comparison

Compare BSP & GMAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bending Spoons S.p.A. Ordinary Shares

BSP

Bending Spoons S.p.A. Ordinary Shares

N/A

Current Price

$32.75

Market Cap

20.8B

Sector

Technology

ML Signal

N/A

GMAB

Genmab A/S ADS

N/A

Current Price

$34.55

Market Cap

20.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BSP
GMAB
Founded
2013
1999
Country
Italy
Denmark
Employees
N/A
N/A
Industry
Computer Software: Programming Data Processing
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
20.8B
20.3B
IPO Year
2023
2008

Fundamental Metrics

Financial Performance
Metric
BSP
GMAB
Price
$32.75
$34.55
Analyst Decision
Buy
Strong Buy
Analyst Count
12
12
Target Price
★ $47.67
$39.14
AVG Volume (30 Days)
★ 2.0M
1.9M
Earning Date
11-06-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$121.36
$23.39
Revenue Next Year
$45.56
$16.04
P/E Ratio
★ N/A
$1.90
Revenue Growth
N/A
N/A
52 Week Low
$30.11
$23.62
52 Week High
$58.94
$35.79

Technical Indicators

Market Signals
Indicator
BSP
GMAB
Relative Strength Index (RSI) 36.85 67.85
Support Level $31.06 $32.38
Resistance Level $36.13 N/A
Average True Range (ATR) 2.25 0.75
MACD -0.55 0.03
Stochastic Oscillator 12.54 94.62

Price Performance

Historical Comparison
BSP
GMAB

About BSP Bending Spoons S.p.A. Ordinary Shares

Bending Spoons SpA acquires and operates digital businesses, focusing on business transformation and operational optimization. Its activities include acquiring companies, implementing operational improvements, and reinvesting in additional acquisitions. The company owns AOL, Brightcove, Eventbrite, Evernote, Harvest, Komoot, Meetup, Remini, StreamYard, Vimeo, and WeTransfer. The majority of revenue is derived from subscriptions, by selling term-based access to its products to individuals and organizations, and the rest from advertising and other sources.

About GMAB Genmab A/S ADS

Genmab is a Copenhagen-based biotechnology company specializing in antibody therapeutics for the treatment of cancer. Genmab's proprietary antibody technologies are DuoBody, HexaBody, DuoHexaBody, and HexElect. Johnson & Johnson partnered with Genmab to create Darzalex, which is regarded as the standard of care for multiple myeloma and is Genmab's leading product. Genmab also has Tepezza for thyroid eye disease (partnered with Horizon), Kesimpta for relapsing multiple sclerosis (partnered with Novartis), Rybrevant (partnered with Johnson & Johnson) for non-small cell lung cancer (NSCLC), Tivdak (partnered with Seagen) for cervical cancer, and Epkinly (partnered with AbbVie) for diffuse large B-cell lymphoma. Genmab has several pipeline candidates targeting other oncologic indications.

Share on Social Networks: